CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
Annual Drug Patent Expirations for CARNITOR Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from two suppliers. There are three…
Annual Drug Patent Expirations for CARNITOR Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from two suppliers. There are three…
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER (esmolol hydrochloride) Hq spclt pharma Patent: 6,528,540 Expiration: Jan 12, 2021 See More … For more information on how DrugPatentWatch can help with…
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+IN+PLASTIC+CONTAINER Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available from one…
New patent expiration for Hq Spclt drug ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
0Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available…
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…
This article was originally published by Abdrhman Mahmoud Gamil in World Journal of Advanced Research and Reviews, 2020, 08(03), 337–349 under a Creative Commons Attribution Liscense 4.0. Abstract Procurement is…
Annual Drug Patent Expirations for ADDERALL+7.5 Adderall 7.5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug. The generic…
